Printed peptide arrays identify prognostic TNC serumantibodies in glioblastoma patients

Liquid biopsies come of age offering unexploited potential to monitor and react to tumor evolution. We developed a cost-effective assay to non-invasively determine the immune status of glioblastoma (GBM) patients. Employing newly developed printed peptide microarrays we assessed the B-cell response...

Descripción completa

Detalles Bibliográficos
Autores principales: Mock, Andreas, Warta, Rolf, Geisenberger, Christoph, Bischoff, Ralf, Schulte, Alexander, Lamszus, Katrin, Stadler, Volker, Felgenhauer, Thomas, Schichor, Christian, Schwartz, Christoph, Matschke, Jakob, Jungk, Christine, Ahmadi, Rezvan, Sahm, Felix, Capper, David, Glass, Rainer, Tonn, Jörg-Christian, Westphal, Manfred, von Deimling, Andreas, Unterberg, Andreas, Bermejo, Justo Lorenzo, Herold-Mende, Christel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537035/
https://www.ncbi.nlm.nih.gov/pubmed/25944688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537035/
https://www.ncbi.nlm.nih.gov/pubmed/25944688

Ejemplares similares